<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="181106-2018"
            EDITION="2018081">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-184058-001</RECEPTION_ID>
      <DELETION_DATE>20180802</DELETION_DATE>
      <FORM_LG_LIST>PL </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>81</NO_OJ>
         <DATE_PUB>20180426</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 081-181106</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="PL">http://ted.europa.eu/udl?uri=TED:NOTICE:181106-2018:TEXT:PL:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>PL</LG_ORIG>
         <ISO_COUNTRY VALUE="PL"/>
         <IA_URL_GENERAL>www.szpitalnowysacz.pl</IA_URL_GENERAL>
         <ORIGINAL_CPV CODE="33652000">Antineoplastic and immunomodulating agents</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="PL218">Nowosądecki</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="PL218">Nowosądecki</n2016:CA_CE_NUTS>
         <n2016:TENDERER_NUTS CODE="PL91">Warszawski stołeczny</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="UKI">LONDON</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="PL514">Miasto Wrocław</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="PL711">Miasto Łódź</n2016:TENDERER_NUTS>
         <VALUES>
            <VALUE TYPE="PROCUREMENT_TOTAL" CURRENCY="PLN">954764.24</VALUE>
         </VALUES>
         <REF_NOTICE>
            <NO_DOC_OJS>2018/S 042-091559</NO_DOC_OJS>
         </REF_NOTICE>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180424</DS_DATE_DISPATCH>
         <AA_AUTHORITY_TYPE CODE="6">Body governed by public law</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="1">Open procedure</PR_PROC>
         <RP_REGULATION CODE="4">European Union</RP_REGULATION>
         <TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="2">The most economic tender</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES>
         <HEADING>01B03</HEADING>
         <INITIATOR>01</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Полша</TI_CY>
            <TI_TOWN>Nowy Sącz</TI_TOWN>
            <TI_TEXT>
               <P>Антинеопластични средства и имуномодулатори</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Polsko</TI_CY>
            <TI_TOWN>Nowy Sącz</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastika a imunomodulátory</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Polen</TI_CY>
            <TI_TOWN>Nowy Sącz</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastiske og immunmodulerende midler</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>Polen</TI_CY>
            <TI_TOWN>Nowy Sącz</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastische und immunmodulierende Mittel</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Πολωνία</TI_CY>
            <TI_TOWN>Nowy Sącz</TI_TOWN>
            <TI_TEXT>
               <P>Αντινεοπλασματικά και ανοσορρυθμιστικά φάρμακα</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>Poland</TI_CY>
            <TI_TOWN>Nowy Sącz</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastic and immunomodulating agents</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Polonia</TI_CY>
            <TI_TOWN>Nowy Sącz</TI_TOWN>
            <TI_TEXT>
               <P>Agentes antineoplásicos e inmunomoduladores</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Poola</TI_CY>
            <TI_TOWN>Nowy Sącz</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastilised ja immuunmoduleerivad ained</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Puola</TI_CY>
            <TI_TOWN>Nowy Sącz</TI_TOWN>
            <TI_TEXT>
               <P>Solunsalpaajat ja sytostaatit sekä immunomodulantit</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>Pologne</TI_CY>
            <TI_TOWN>Nowy Sącz</TI_TOWN>
            <TI_TEXT>
               <P>Antinéoplasiques et immunomodulateurs</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Pholainn, an</TI_CY>
            <TI_TOWN>Nowy Sącz</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastic and immunomodulating agents</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Poljska</TI_CY>
            <TI_TOWN>Nowy Sącz</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastični lijekovi i imunomodulatori</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Lengyelország</TI_CY>
            <TI_TOWN>Nowy Sącz</TI_TOWN>
            <TI_TEXT>
               <P>Daganatellenes és immunmodulátor szerek</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Polonia</TI_CY>
            <TI_TOWN>Nowy Sącz</TI_TOWN>
            <TI_TEXT>
               <P>Agenti antineoplastici e immunomodulatori</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Lenkija</TI_CY>
            <TI_TOWN>Nowy Sącz</TI_TOWN>
            <TI_TEXT>
               <P>Antinavikiniai vaistai ir imunomoduliatoriai</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Polija</TI_CY>
            <TI_TOWN>Nowy Sącz</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastiskie līdzekļi un imūnmodulatori</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>il-Polonja</TI_CY>
            <TI_TOWN>Nowy Sącz</TI_TOWN>
            <TI_TEXT>
               <P>Aġenti ta' l-antineoplastika u ta' l-immunomodulaturi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Polen</TI_CY>
            <TI_TOWN>Nowy Sącz</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastische en immunomodulerende middelen</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Polska</TI_CY>
            <TI_TOWN>Nowy Sącz</TI_TOWN>
            <TI_TEXT>
               <P>Środki przeciwnowotworowe i immunomodulacyjne</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>Polónia</TI_CY>
            <TI_TOWN>Nowy Sącz</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplásicos e imunomoduladores</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Polonia</TI_CY>
            <TI_TOWN>Nowy Sącz</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplazice şi imunomodulatoare</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Poľsko</TI_CY>
            <TI_TOWN>Nowy Sącz</TI_TOWN>
            <TI_TEXT>
               <P>Antineoplastické a imunomodulačné činidlá</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Poljska</TI_CY>
            <TI_TOWN>Nowy Sącz</TI_TOWN>
            <TI_TEXT>
               <P>Zdravila z delovanjem na novotvorbe in imunomodulatorji</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Polen</TI_CY>
            <TI_TOWN>Nowy Sącz</TI_TOWN>
            <TI_TEXT>
               <P>Cytostatika/cytotoxiska medel och immunmodulerande medel</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="PL">Szpital Specjalistyczny im. Jędrzeja Śniadeckiego</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <F03_2014 CATEGORY="ORIGINAL" FORM="F03" LG="PL">
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>Szpital Specjalistyczny im. Jędrzeja Śniadeckiego</OFFICIALNAME>
               <ADDRESS>ul. Młyńska 10</ADDRESS>
               <TOWN>Nowy Sącz</TOWN>
               <POSTAL_CODE>33-300</POSTAL_CODE>
               <COUNTRY VALUE="PL"/>
               <CONTACT_POINT>Zespół ds. zamówień publicznych</CONTACT_POINT>
               <PHONE>+48 184436635</PHONE>
               <E_MAIL>zamowieniapubliczne@szpitalnowysacz.pl</E_MAIL>
               <FAX>+48 184436635</FAX>
               <n2016:NUTS CODE="PL218"/>
               <URL_GENERAL>www.szpitalnowysacz.pl</URL_GENERAL>
            </ADDRESS_CONTRACTING_BODY>
            <CA_TYPE VALUE="BODY_PUBLIC"/>
            <CA_ACTIVITY VALUE="HEALTH"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT>
            <TITLE>
               <P>Dostawa leków przeciwnowotworowych</P>
            </TITLE>
            <REFERENCE_NUMBER>271-16/18</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33652000"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>2. Przedmiot zamówienia jest podzielony na 4 części</P>
               <P>Zadanie nr 1 – Enzalutamid</P>
               <P>Zadanie nr 2 - Ozymertynib</P>
               <P>Zadanie nr 3 - Kobymetynib</P>
               <P>Zadanie nr 4 - Ruksolitynib</P>
            </SHORT_DESCR>
            <VAL_TOTAL CURRENCY="PLN">954764.24</VAL_TOTAL>
            <LOT_DIVISION/>
            <OBJECT_DESCR ITEM="1">
               <TITLE>
                  <P>Enzalutamid</P>
               </TITLE>
               <LOT_NO>1</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33652000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="PL218"/>
               <MAIN_SITE>
                  <P>Siedziba Zamawiającego - Apteka Szpitalna.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>Enzalutamid.</P>
               </SHORT_DESCR>
               <AC_COST>
                  <AC_CRITERION>Cena</AC_CRITERION>
                  <AC_WEIGHTING>60</AC_WEIGHTING>
               </AC_COST>
               <AC_COST>
                  <AC_CRITERION>Warunki dostawy</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="2">
               <TITLE>
                  <P>Ozymertynib</P>
               </TITLE>
               <LOT_NO>2</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33652000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="PL218"/>
               <MAIN_SITE>
                  <P>Siedziba Zamawiającego - Apteka Szpitalna.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>Ozymertynib.</P>
               </SHORT_DESCR>
               <AC_COST>
                  <AC_CRITERION>Cena</AC_CRITERION>
                  <AC_WEIGHTING>60</AC_WEIGHTING>
               </AC_COST>
               <AC_COST>
                  <AC_CRITERION>Warunki dostawy</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="3">
               <TITLE>
                  <P>Kobymetynib</P>
               </TITLE>
               <LOT_NO>3</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33652000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="PL218"/>
               <MAIN_SITE>
                  <P>Siedziba Zamawiającego - Apteka Szpitalna.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>Kobymetynib.</P>
               </SHORT_DESCR>
               <AC_COST>
                  <AC_CRITERION>Cena</AC_CRITERION>
                  <AC_WEIGHTING>60</AC_WEIGHTING>
               </AC_COST>
               <AC_COST>
                  <AC_CRITERION>Warunki dostawy</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="4">
               <TITLE>
                  <P>Ruksolitynib</P>
               </TITLE>
               <LOT_NO>4</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33652000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="PL218"/>
               <MAIN_SITE>
                  <P>Siedziba Zamawiającego - Apteka Szpitalna.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>Ruksolitynib.</P>
               </SHORT_DESCR>
               <AC_COST>
                  <AC_CRITERION>Cena</AC_CRITERION>
                  <AC_WEIGHTING>60</AC_WEIGHTING>
               </AC_COST>
               <AC_COST>
                  <AC_CRITERION>Warunki dostawy</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_COST>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <PROCEDURE>
            <PT_OPEN/>
            <NO_CONTRACT_COVERED_GPA/>
            <NOTICE_NUMBER_OJ>2018/S 042-091559</NOTICE_NUMBER_OJ>
         </PROCEDURE>
         <AWARD_CONTRACT ITEM="1">
            <CONTRACT_NO>1</CONTRACT_NO>
            <LOT_NO>1</LOT_NO>
            <TITLE>
               <P>Enzalutamid</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-04-24</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NB_TENDERS_RECEIVED_SME>0</NB_TENDERS_RECEIVED_SME>
               <NB_TENDERS_RECEIVED_OTHER_EU>0</NB_TENDERS_RECEIVED_OTHER_EU>
               <NB_TENDERS_RECEIVED_NON_EU>0</NB_TENDERS_RECEIVED_NON_EU>
               <NB_TENDERS_RECEIVED_EMEANS>0</NB_TENDERS_RECEIVED_EMEANS>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Astellas Pharma Sp. z o.o.</OFFICIALNAME>
                     <TOWN>Warszawa</TOWN>
                     <COUNTRY VALUE="PL"/>
                     <n2016:NUTS CODE="PL91"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="PLN">189763.28</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="2">
            <CONTRACT_NO>2</CONTRACT_NO>
            <LOT_NO>2</LOT_NO>
            <TITLE>
               <P>Ozymertynib</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-04-24</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NB_TENDERS_RECEIVED_SME>0</NB_TENDERS_RECEIVED_SME>
               <NB_TENDERS_RECEIVED_OTHER_EU>1</NB_TENDERS_RECEIVED_OTHER_EU>
               <NB_TENDERS_RECEIVED_NON_EU>0</NB_TENDERS_RECEIVED_NON_EU>
               <NB_TENDERS_RECEIVED_EMEANS>0</NB_TENDERS_RECEIVED_EMEANS>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Astra Zeneca UK Limited</OFFICIALNAME>
                     <TOWN>Cambridge</TOWN>
                     <COUNTRY VALUE="UK"/>
                     <n2016:NUTS CODE="UKI"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="PLN">431199.93</VAL_TOTAL>
               <LIKELY_SUBCONTRACTED/>
               <VAL_SUBCONTRACTING CURRENCY="PLN">399259.20</VAL_SUBCONTRACTING>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="3">
            <CONTRACT_NO>3</CONTRACT_NO>
            <LOT_NO>3</LOT_NO>
            <TITLE>
               <P>Kobymetynib</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-04-24</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NB_TENDERS_RECEIVED_SME>0</NB_TENDERS_RECEIVED_SME>
               <NB_TENDERS_RECEIVED_OTHER_EU>0</NB_TENDERS_RECEIVED_OTHER_EU>
               <NB_TENDERS_RECEIVED_NON_EU>0</NB_TENDERS_RECEIVED_NON_EU>
               <NB_TENDERS_RECEIVED_EMEANS>0</NB_TENDERS_RECEIVED_EMEANS>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Roche Polska Sp. z o.o.</OFFICIALNAME>
                     <TOWN>Warszawa</TOWN>
                     <COUNTRY VALUE="PL"/>
                     <n2016:NUTS CODE="PL91"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="PLN">140124.49</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="4">
            <CONTRACT_NO>4</CONTRACT_NO>
            <LOT_NO>4</LOT_NO>
            <TITLE>
               <P>Ruksolitynib</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-04-24</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NB_TENDERS_RECEIVED_SME>0</NB_TENDERS_RECEIVED_SME>
               <NB_TENDERS_RECEIVED_OTHER_EU>0</NB_TENDERS_RECEIVED_OTHER_EU>
               <NB_TENDERS_RECEIVED_NON_EU>0</NB_TENDERS_RECEIVED_NON_EU>
               <NB_TENDERS_RECEIVED_EMEANS>0</NB_TENDERS_RECEIVED_EMEANS>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Urtica Sp. z o.o.</OFFICIALNAME>
                     <TOWN>Wrocław</TOWN>
                     <COUNTRY VALUE="PL"/>
                     <n2016:NUTS CODE="PL514"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>PGF S.A.</OFFICIALNAME>
                     <TOWN>Łódź</TOWN>
                     <COUNTRY VALUE="PL"/>
                     <n2016:NUTS CODE="PL711"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">270057.67</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <COMPLEMENTARY_INFO>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>Prezes Krajowej Izby Odwoławczej</OFFICIALNAME>
               <ADDRESS>ul. Postępu 17A</ADDRESS>
               <TOWN>Warszawa</TOWN>
               <POSTAL_CODE>02-676</POSTAL_CODE>
               <COUNTRY VALUE="PL"/>
               <PHONE>+48 224587801</PHONE>
               <FAX>+48 224587800</FAX>
               <URL>http://www.uzp.gov.pl</URL>
            </ADDRESS_REVIEW_BODY>
            <ADDRESS_REVIEW_INFO>
               <OFFICIALNAME>Urząd Zamówień Publicznych – Departament Odwołań</OFFICIALNAME>
               <ADDRESS>ul. Postępu 17A</ADDRESS>
               <TOWN>Warszawa</TOWN>
               <POSTAL_CODE>02-676</POSTAL_CODE>
               <COUNTRY VALUE="PL"/>
               <PHONE>+48 224587801</PHONE>
               <E_MAIL>odwolania@uzp.gov.pl</E_MAIL>
               <FAX>+48 224587800</FAX>
               <URL>http://www.uzp.gov.pl</URL>
            </ADDRESS_REVIEW_INFO>
            <DATE_DISPATCH_NOTICE>2018-04-24</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F03_2014>
   </FORM_SECTION>
</TED_EXPORT>
